Spencer J. Johnson
Claims of Genentech’s Carter ’213 Patent Found Unpatentable
Biosimilars Law Bulletin ·
First IPR Against Biogen’s ’172 Patent Instituted After Multiple Attempts
Biosimilars Law Bulletin ·
Litigation Spotlight Update: Epogen® Litigation Status in Face of Retacrit Regulatory Approval
Biosimilars Law Bulletin ·